New heart monitor aims to keep patients out of hospital

NCT ID NCT06641921

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a remote monitoring system called Seerlinq HeartCore in 330 heart failure patients. Participants used a device at home to measure heart function and report symptoms. The goal was to see if this approach could reduce hospitalizations and deaths over 6 months. The results could improve how doctors manage heart failure remotely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Seerlinq HeartCore telemedical monitoring system (device)

What this could lead to

If successful, this could show that remote monitoring helps heart failure patients avoid hospital stays and live longer at home.

What could go wrong

This is a single-arm trial without a comparison group, so benefits may be due to other factors. The device is not a cure and requires ongoing medication adjustments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Premedix Clinic

    Bratislava, Nové Mesto, 831 01, Slovakia